Tapering csDMARD or TNFi first: is the risk of flares different for ACPA-positive or ACPA-negative rheumatoid arthritis?

• Annette H M van der Helm-van Mil,
• Pascal H P de Jong,
• Elise van Mulligen,
• Agnes E M Looijen,
• Judith W Heutz

Affiliations

Annette H M van der Helm-van Mil

Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands

Pascal H P de Jong

Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands

Elise van Mulligen

Department of Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands

Agnes E M Looijen

Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands

Judith W Heutz

Department of Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands